2020
DOI: 10.2147/cmar.s266807
|View full text |Cite
|
Sign up to set email alerts
|

<p>Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid Carcinoma</p>

Abstract: Introduction: Gene expression association studies of tumor samples have uncovered several long non-coding RNAs (lncRNAs) closely related to various types of cancer. Several lncRNAs have been reported to play essential roles in the progression of papillary thyroid carcinoma (PTC). Novel lncRNA inhibiting proliferation and metastasis (lnc-NLIPMT) is a known regulator of mammary cell proliferation and motility, but its involvement in PTC is unclear. Materials and Methods: We investigated the role of lnc-NLIPMT in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…The percentage of positive cells was graded as: 1 (0-25%), 2 (26-50%), 3 (51-75%), or 4 (76-100%). The expression of SNRPC were defined according to the final one obtained from the grade of intensity multiplied by the score of the percentage of positive cells: low SNRPC expression (0-5) and high SNRPC expression (6)(7)(8)(9)(10)(11)(12). clinicopathological features.…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%
See 1 more Smart Citation
“…The percentage of positive cells was graded as: 1 (0-25%), 2 (26-50%), 3 (51-75%), or 4 (76-100%). The expression of SNRPC were defined according to the final one obtained from the grade of intensity multiplied by the score of the percentage of positive cells: low SNRPC expression (0-5) and high SNRPC expression (6)(7)(8)(9)(10)(11)(12). clinicopathological features.…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%
“…Recently, high throughput assays and bioinformatic tools have been widely used to screen for novel differentially expressed genes (DEGs) involved in cancers [7,8]. However, results based only on single microarray data have the limitation of a high false-positive rate.…”
Section: Introductionmentioning
confidence: 99%